MA25590A1 - Agent actif de delivraison de poudre seche - Google Patents

Agent actif de delivraison de poudre seche

Info

Publication number: MA25590A1
Authority: MA; Morocco
Prior art keywords: active agent; dry powder; powder delivery; delivery; dry
Prior art date: 1998-09-14

Application number

MA25762A

Other languages

English (en)

Inventor

Clark Andrew

Chang Kuo Mei

John Aldous Barry

Lalor Cecily

Original Assignee

Inhale Therapeutic Syst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-14

Filing date

1999-09-09

Publication date

2002-12-31

1999-09-09 Application filed by Inhale Therapeutic Syst filed Critical Inhale Therapeutic Syst

2002-12-31 Publication of MA25590A1 publication Critical patent/MA25590A1/fr

Links

239000013543 active substance Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Otolaryngology (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)

MA25762A 1998-09-14 1999-09-09 Agent actif de delivraison de poudre seche MA25590A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10016398P	1998-09-14	1998-09-14

Publications (1)

Publication Number	Publication Date
MA25590A1 true MA25590A1 (fr)	2002-12-31

Family

ID=22278404

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA25762A MA25590A1 (fr)	1998-09-14	1999-09-09	Agent actif de delivraison de poudre seche

Country Status (44)

Country	Link
EP (1)	EP1117442A1 (fr)
JP (1)	JP2002524535A (fr)
KR (1)	KR20010075063A (fr)
CN (1)	CN1317977A (fr)
AP (1)	AP1374A (fr)
AR (1)	AR022090A1 (fr)
AU (1)	AU753014B2 (fr)
BG (1)	BG105430A (fr)
BR (1)	BR9913722A (fr)
CA (1)	CA2343920A1 (fr)
CO (1)	CO5130023A1 (fr)
CZ (1)	CZ2001829A3 (fr)
DZ (1)	DZ2892A1 (fr)
EA (1)	EA003476B1 (fr)
EE (1)	EE200100151A (fr)
GE (1)	GEP20043257B (fr)
GT (1)	GT199900156A (fr)
HK (1)	HK1042231A1 (fr)
HN (1)	HN1999000159A (fr)
HR (1)	HRP20010189A2 (fr)
HU (1)	HUP0103837A3 (fr)
ID (1)	ID28845A (fr)
IL (2)	IL141562A0 (fr)
IS (1)	IS5878A (fr)
LT (1)	LT4897B (fr)
LV (1)	LV12658B (fr)
MA (1)	MA25590A1 (fr)
MY (1)	MY129282A (fr)
NO (1)	NO20011251L (fr)
NZ (1)	NZ510168A (fr)
OA (1)	OA11781A (fr)
PA (1)	PA8481901A1 (fr)
PE (1)	PE20001061A1 (fr)
PL (1)	PL195574B1 (fr)
SA (1)	SA99200718B1 (fr)
SK (1)	SK3442001A3 (fr)
TN (1)	TNSN99173A1 (fr)
TR (1)	TR200101182T2 (fr)
TW (1)	TWI226248B (fr)
UA (1)	UA76085C2 (fr)
UY (1)	UY25711A1 (fr)
WO (1)	WO2000015262A1 (fr)
YU (1)	YU24201A (fr)
ZA (1)	ZA200101995B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6956021B1 (en)	1998-08-25	2005-10-18	Advanced Inhalation Research, Inc.	Stable spray-dried protein formulations
HK1049621A1 (zh)	1999-06-09	2003-05-23	罗伯特‧E‧希弗斯	超临界流体辅助的喷雾和鼓泡乾燥
US6475468B2 (en) *	2001-02-15	2002-11-05	Aeropharm Technology Incorporated	Modulated release particles for aerosol delivery
JP2005503425A (ja) *	2001-05-24	2005-02-03	アレックザモレキュラーデリヴァリーコーポレイション	所定の吸入ルートによる薬剤エステルの送出
EG24184A (en) *	2001-06-15	2008-10-08	Otsuka Pharma Co Ltd	Dry powder inhalation system for transpulmonary
AU2002352836B2 (en)	2001-11-20	2005-09-29	Alkermes, Inc.	Improved particulate compositions for pulmonary delivery
CA2477245A1 (fr)	2002-02-25	2003-09-04	Diffusion Pharmaceuticals Llc	Sels carotenoides trans bipolaires et leurs utilisations
US7759506B2 (en)	2002-02-25	2010-07-20	Diffusion Pharmaceuticals Llc	Bipolar trans carotenoid salts and their uses
WO2004004798A2 (fr) *	2002-07-03	2004-01-15	The Brigham And Women's Hospital, Inc.	Introduction par les voies aeriennes centrales pour l'administration systemique d'agents therapeutiques
EP1575563B1 (fr) *	2002-12-19	2007-02-14	Pharmacia Corporation	Formulation a caractere non-hygroscopique comprenant un principe actif hydroscopique
DE10338403A1 (de) *	2003-08-18	2005-03-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum
GB0327723D0 (en) *	2003-09-15	2003-12-31	Vectura Ltd	Pharmaceutical compositions
US20070020299A1 (en)	2003-12-31	2007-01-25	Pipkin James D	Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
CN101098678A (zh)	2004-04-23	2008-01-02	锡德克斯公司	含有磺基烷基醚环糊精的dpi制剂
EP2540696B1 (fr)	2005-02-24	2020-01-01	Diffusion Pharmaceuticals LLC	Transcaroténoïdes, formulation les comprenant et leurs utilisations
BRPI0608844A2 (pt) *	2005-03-09	2010-02-02	Ono Pharmaceutical Co	partìcula e preparação que contém a partìcula
US7629331B2 (en)	2005-10-26	2009-12-08	Cydex Pharmaceuticals, Inc.	Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
PT2583668E (pt)	2005-10-26	2015-01-05	Cydex Pharmaceuticals Inc	Composições de éter sulfoalquílico de ciclodextrina e métodos para a sua preparação
WO2008021451A2 (fr) *	2006-08-14	2008-02-21	Aktiv-Dry Llc	Inhalateur à poudre sèche actionné par l'homme et compositions à inhaler sous forme de poudre sèche
JP5315056B2 (ja) *	2006-10-25	2013-10-16	大日本住友製薬株式会社	固結抑制粒状製剤
EP1925295A1 (fr) *	2006-11-22	2008-05-28	Boehringer Ingelheim Pharma GmbH & Co. KG	Formule de poudre stable contenant un nouveau anticholinergique
CN101687757A (zh)	2007-04-13	2010-03-31	扩散药品有限公司	双极性反式类胡萝卜素作为预治疗及其在周围血管疾病的治疗中的应用
US12370352B2 (en)	2007-06-28	2025-07-29	Cydex Pharmaceuticals, Inc.	Nasal and ophthalmic delivery of aqueous corticosteroid solutions
KR20100083820A (ko)	2007-10-31	2010-07-22	디퓨젼 파마슈티컬즈 엘엘씨	저분자 확산을 촉진시키는 신규한 치료요법
ES2661215T3 (es)	2009-05-20	2018-03-28	Aeras	Composiciones víricas; inmunógenas; secadas por pulverización; estables
EP2445339B1 (fr)	2009-06-22	2019-08-07	Diffusion Pharmaceuticals LLC	Composé améliorant la diffusion et son utilisation avec un thrombolytique
AU2011262361A1 (en)	2010-06-02	2013-01-10	Diffusion Pharmaceuticals Llc	Oral formulations of bipolar trans carotenoids
KR102240042B1 (ko) *	2012-05-03	2021-04-14	얀센 사이언시즈 아일랜드 언리미티드 컴퍼니	상기도 감염 치료용 폴리이노신산-폴리사이티딜산(폴리 (i:c)) 제형
BR112015010601B1 (pt) *	2012-11-09	2022-07-19	Civitas Therapeutics, Inc.	Composição farmacêutica e uso da composição
US20180043585A9 (en) *	2013-09-20	2018-02-15	Virginia Commonwealth University	Delivery of particles using hygroscopic excipients
MX392636B (es)	2014-10-31	2025-03-24	Glaxosmithkline Ip Dev Ltd	Formulacion en polvo.
CA3018550A1 (fr)	2016-03-24	2017-09-28	Diffusion Pharmaceuticals Llc	Utilisation de carotenoides trans bipolaires avec une chimiotherapie et une radiotherapie en vue du traitement d'un cancer
US20220378727A1 (en) *	2021-05-14	2022-12-01	The University Of Hong Kong	Dry powder formulations of tamibarotene for pulmonary and intranasal delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3155573A (en) *	1958-05-06	1964-11-03	Benger Lab Ltd	Inhalant composition and method of making same
CA2115065C (fr) *	1992-06-12	2000-10-03	Kiyoyuki Sakon	Poudre particulaire ultrafine pour inhalation et methode de production
US6524557B1 (en) *	1994-12-22	2003-02-25	Astrazeneca Ab	Aerosol formulations of peptides and proteins
US5874064A (en)	1996-05-24	1999-02-23	Massachusetts Institute Of Technology	Aerodynamically light particles for pulmonary drug delivery
CA2277801C (fr) *	1997-01-16	2002-10-15	Massachusetts Institute Of Technology	Preparation de particules pour inhalation
US6086376A (en) *	1998-01-30	2000-07-11	Rtp Pharma Inc.	Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

1999
- 1999-09-09 MA MA25762A patent/MA25590A1/fr unknown
- 1999-09-13 HN HN1999000159A patent/HN1999000159A/es unknown
- 1999-09-13 DZ DZ990192A patent/DZ2892A1/fr active
- 1999-09-13 CA CA002343920A patent/CA2343920A1/fr not_active Abandoned
- 1999-09-13 HU HU0103837A patent/HUP0103837A3/hu unknown
- 1999-09-13 YU YU24201A patent/YU24201A/sh unknown
- 1999-09-13 CZ CZ2001829A patent/CZ2001829A3/cs unknown
- 1999-09-13 ID IDW20010582A patent/ID28845A/id unknown
- 1999-09-13 CN CN99810871A patent/CN1317977A/zh active Pending
- 1999-09-13 AP APAP/P/2001/002093A patent/AP1374A/en active
- 1999-09-13 PE PE1999000925A patent/PE20001061A1/es not_active Application Discontinuation
- 1999-09-13 TW TW088115876A patent/TWI226248B/zh not_active IP Right Cessation
- 1999-09-13 KR KR1020017003208A patent/KR20010075063A/ko not_active Ceased
- 1999-09-13 PL PL99346768A patent/PL195574B1/pl not_active IP Right Cessation
- 1999-09-13 IL IL14156299A patent/IL141562A0/xx not_active IP Right Cessation
- 1999-09-13 TR TR2001/01182T patent/TR200101182T2/xx unknown
- 1999-09-13 NZ NZ510168A patent/NZ510168A/en unknown
- 1999-09-13 ZA ZA200101995A patent/ZA200101995B/en unknown
- 1999-09-13 JP JP2000569846A patent/JP2002524535A/ja not_active Withdrawn
- 1999-09-13 OA OA1200100063A patent/OA11781A/en unknown
- 1999-09-13 EA EA200100300A patent/EA003476B1/ru active IP Right Revival
- 1999-09-13 SK SK344-2001A patent/SK3442001A3/sk unknown
- 1999-09-13 EP EP99969035A patent/EP1117442A1/fr not_active Withdrawn
- 1999-09-13 EE EEP200100151A patent/EE200100151A/xx unknown
- 1999-09-13 HK HK02101738.3A patent/HK1042231A1/zh unknown
- 1999-09-13 GE GEAP19995857A patent/GEP20043257B/en unknown
- 1999-09-13 MY MYPI99003947A patent/MY129282A/en unknown
- 1999-09-13 BR BR9913722-4A patent/BR9913722A/pt not_active IP Right Cessation
- 1999-09-13 AU AU60397/99A patent/AU753014B2/en not_active Ceased
- 1999-09-13 UA UA2001031707A patent/UA76085C2/uk unknown
- 1999-09-13 HR HR20010189A patent/HRP20010189A2/hr not_active Application Discontinuation
- 1999-09-13 WO PCT/US1999/021109 patent/WO2000015262A1/fr not_active Ceased
- 1999-09-13 AR ARP990104587A patent/AR022090A1/es unknown
- 1999-09-14 UY UY25711A patent/UY25711A1/es not_active Application Discontinuation
- 1999-09-14 TN TNTNSN99173A patent/TNSN99173A1/fr unknown
- 1999-09-14 GT GT199900156A patent/GT199900156A/es unknown
- 1999-09-14 PA PA19998481901A patent/PA8481901A1/es unknown
- 1999-09-14 CO CO99058265A patent/CO5130023A1/es unknown
- 1999-10-31 SA SA99200718A patent/SA99200718B1/ar unknown
2001
- 2001-02-21 IL IL141562A patent/IL141562A/en unknown
- 2001-03-05 IS IS5878A patent/IS5878A/is unknown
- 2001-03-13 NO NO20011251A patent/NO20011251L/no not_active Application Discontinuation
- 2001-03-14 LV LV010041A patent/LV12658B/xx unknown
- 2001-03-14 LT LT2001021A patent/LT4897B/lt not_active IP Right Cessation
- 2001-04-10 BG BG105430A patent/BG105430A/xx unknown

Also Published As

Publication number	Publication date
KR20010075063A (ko)	2001-08-09
TR200101182T2 (tr)	2001-09-21
NZ510168A (en)	2003-09-26
CO5130023A1 (es)	2002-02-27
ID28845A (id)	2001-07-05
MY129282A (en)	2007-03-30
OA11781A (en)	2005-07-26
HUP0103837A3 (en)	2002-11-28
NO20011251D0 (no)	2001-03-13
BG105430A (en)	2001-12-29
YU24201A (sh)	2003-08-29
AR022090A1 (es)	2002-09-04
AU753014B2 (en)	2002-10-03
LT2001021A (en)	2001-11-26
EA003476B1 (ru)	2003-06-26
EP1117442A1 (fr)	2001-07-25
PL195574B1 (pl)	2007-10-31
IL141562A (en)	2007-07-24
AP2001002093A0 (en)	2001-03-31
TWI226248B (en)	2005-01-11
SK3442001A3 (en)	2001-11-06
LT4897B (lt)	2002-02-25
CZ2001829A3 (cs)	2001-09-12
PL346768A1 (en)	2002-02-25
EE200100151A (et)	2002-06-17
LV12658B (lv)	2001-09-20
UY25711A1 (es)	1999-11-17
JP2002524535A (ja)	2002-08-06
EA200100300A1 (ru)	2001-10-22
WO2000015262A1 (fr)	2000-03-23
NO20011251L (no)	2001-04-17
IL141562A0 (en)	2002-03-10
TNSN99173A1 (fr)	2005-11-10
GEP20043257B (en)	2004-06-25
GT199900156A (es)	2001-03-07
AP1374A (en)	2005-02-28
ZA200101995B (en)	2002-03-11
HRP20010189A2 (en)	2005-04-30
LV12658A (lv)	2001-05-20
UA76085C2 (en)	2006-07-17
IS5878A (is)	2001-03-05
SA99200718B1 (ar)	2006-11-04
BR9913722A (pt)	2001-05-29
PE20001061A1 (es)	2000-10-08
CN1317977A (zh)	2001-10-17
HK1042231A1 (zh)	2002-08-09
HUP0103837A2 (hu)	2002-05-29
DZ2892A1 (fr)	2003-12-15
HN1999000159A (es)	1999-11-11
PA8481901A1 (es)	2002-04-25
AU6039799A (en)	2000-04-03
CA2343920A1 (fr)	2000-03-23

Publication	Publication Date	Title
MA25590A1 (fr)	2002-12-31	Agent actif de delivraison de poudre seche
MA26033A1 (fr)	2004-04-01	Agent active de livraison aerosol
IL149554A0 (en)	2002-11-10	Fungicidal combinations of active substances
IS5248A (is)	1999-11-15	Lyfjasamsetningar sem innihalda vorikónasól
DE60039829D1 (de)	2008-09-25	Pulversprühpistole
IS6263A (is)	2002-02-08	Lyfjasamsetningar, sem innihalda trípeptíð
DE69826704D1 (de)	2004-11-04	Pleuromutlin-derivate als antimikrobielles wirkungsmittel
GB0216125D0 (en)	2002-08-21	Fibers providing controlled active agent delivery
EP1487417A4 (fr)	2010-03-17	Formulations de medicament en poudre seche
EE200000595A (et)	2002-04-15	Toimeaine viimine kandjamaatriksisse
NO20015670D0 (no)	2001-11-20	Forbedrede farmasöytiske formuleringer
PT1227724E (pt)	2004-09-30	Agente herbicida
HUP0105229A3 (en)	2004-06-28	Fungicidal active substance combinations
PL355623A1 (en)	2004-05-04	Fungicidally active substance combinations
NO20005880D0 (no)	2000-11-21	Bioreduktive cytotoksiske midler
FR2797156B1 (fr)	2002-03-01	Distributeur de poudre
DE69905278D1 (de)	2003-03-13	Insectizide mittel
DE60019505D1 (de)	2005-05-25	Mikrobizide Wirksubstanzen
ES1048018Y (es)	2001-10-16	Paquete de cigarrillos.
ZA200202759B (en)	2003-06-25	Synergistic herbicidal active substance combinations.
HUP0201986A3 (en)	2005-01-28	Fungicidal combinations of active substances
FR2796699B1 (fr)	2001-10-12	Distributeur rotatif de poudre
GB2351221B (en)	2003-07-23	Animal cage
ZA200202777B (en)	2003-09-23	Dosage unit for dry powder medicament.
DE50001741D1 (de)	2003-05-15	Atemzugskontrolliertes Inhalationsgerät für Trockenpulver